Dec 25, 2025 · Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of rare metabolic diseases.

Dec 11, 2025 · In general, an eagle is any bird of prey more powerful than a buteo. An eagle may resemble a vulture in build and flight characteristics but has a fully feathered (often crested) head …

Eagles are large, powerfully-built birds of prey, with heavy heads and beaks.

The latest Aeglea BioTherapeutics stock prices, stock quotes, news, and AGLE history to help you invest and trade smarter.

Nov 27, 2023 · /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with best-in-class...

Spyre Therapeutics, Inc. (NASDAQ: AGLE) is a biotechnology company dedicated to advancing a robust pipeline of antibody therapeutics aimed at transforming the treatment of inflammatory bowel …

Jun 22, 2023 · Aeglea BioTherapeutics Inc (NASDAQ: AGLE) has acquired Spyre Therapeutics, a privately-held biotechnology company focused on developing antibody therapeutics for inflammatory …

Explore our latest Raptor Radio podcast, educational videos, live eagle cams, and other exciting content! Over 30 Years of Experience in Protecting Bald Eagles and other Birds of Prey!

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Nov 9, 2023 · Looking to buy Aeglea BioTherapeutics Stock? Get the latest AGLE quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.